Aureka Biotechnologies announced the completion of a US$100 million Series B financing round on August 10, 2026. Granite Asia provided the first tranche as the sole investor, while a leading …
A growing school of thought within artificial intelligence suggests that the long-term competitive advantage in AI may no longer reside primarily in the models themselves. As advanced AI systems increasingly …
Marking more than 15 years of partnership with Europe’s drug discovery community, Viva Biotech is reinforcing its dedication to the region through operational consistency, steady growth, and scalable collaboration. As …
Insilico Medicine, a clinical-stage biotechnology company specializing in generative artificial intelligence (AI) for drug discovery and development, has announced a strategic research partnership with ASKA Pharmaceutical Co., Ltd. (“ASKA”), a …
Basecamp Research, a cutting-edge AI lab focused on biological design, has unveiled the Trillion Gene Atlas—an ambitious scientific program aimed at generating and modeling genomic data at an unprecedented trillion-gene …
